Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: The Fred Hutchinson Cancer Research Center experience

Biology of Blood and Marrow Transplantation

Volumn 7, Issue 12 SUPPL. 1, 2001, Pages 11S-15S

  Nichols, W Garrett ^a   Gooley, Ted ^a   Boeckh, Michael ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Hematopoietic stem cell transplant; Parainfluenza virus; Respiratory syncytial virus

Indexed keywords

RIBAVIRIN;

ARTICLE; CLINICAL TRIAL; COMMUNICABLE DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION CONTROL; METHODOLOGY; OPPORTUNISTIC INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; VIROLOGY; VIRUS INFECTION;

CLINICAL TRIALS; COMMUNICABLE DISEASE CONTROL; COMMUNITY-ACQUIRED INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; OPPORTUNISTIC INFECTIONS; PARAMYXOVIRIDAE INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RETROSPECTIVE STUDIES; RIBAVIRIN; RISK FACTORS; SURVIVAL RATE;

EID: 0035747320     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2001.v7.pm11777098     Document Type: Article

References (11)

1. Bowden RA. Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience. Am J Med. 1997;102(3A):27-30.
2. Englund JA, Anderson LJ, Rhame FS. Nosocomial transmission of respiratory syncytial virus in immunocompromised adults. J Clin Microbiol. 1991;29:115-119.
3. Elting LS, Whimbey E, Lo W, Couch R, Andreeff M, Bodey GP. Epidemiology of influenza A virus infection in patients with acute or chronic leukemia. Support Care Cancer. 1995;3:198-202.
4. Couch RB, Englund JA, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med. 1997;102(3A):2-9.
5. Garcia R, Raad I, Abi-Said D, et al. Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients. Infect Control Hosp Epidemiol. 1997;18:412-416.
6. Boeckh M, Gooley T, Bowden RA, et al. Risk factors for progression from respiratory syncytial virus upper respiratory tract infection to pneumonia after hematopoietic stem cell transplantation. Presented at the 39th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; 1999; San Francisco, Calif.
7. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood. 2001;98:573-578.
8. Harrington RD, Hooton TM, Hackman RC, et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis. 1992;165:987-993.
9. Whimbey E, Couch RB, Englund JA, et al. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin Infect Dis. 1995;21:376-379.
10. Lewinsohn DM, Bowden RA, Mattson D, Crawford SW. Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation. Antimicrob Agent Chemother. 1996;40:2555-2557.
11. Ghosh S, Champlin R, Englund J, et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant. 2000;25:751-755.